Diphenhydramine

Producers shown on SFDA

(Record date:20/10/2021）

Producers shown on EP

Not showing any

Producer:Shanghai SPH New Asia Pharmaceutical Co., Ltd. (Shanghai New Asia Pharmaceutical Co., Ltd.) is a subsidiary of Shanghai Pharmaceutical Group Co., Ltd. The company's flagship products, such as ceftriaxone, cefotaxime, cefoperazone, cefotiam and cefazolin, enjoy a good reputation in the domestic market.

Staff size:900-999 persons

Registered capital:RMB 1 billion 52 million 429 thousand and 132

Producer:Qidong Dongyue Pharmaceutical Co., Ltd. was founded in 2001, with about 300 employees, covering an area of 110192 square meters (about 160 mu). The factory fully implements cGMP management and has successively passed China GMP certification, Japan PMDA certification and US FDA certification.
Staff size:200-299 persons

Registered capital:RMB 7.76 million

After more than 50 years of accumulation and development, the company now has 104 drug production approval numbers, including 20 APIs and 84 preparations. The leading varieties of API are acetaminophen, chlorpipetin hydrochloride, nefopam hydrochloride, procaine hydrochloride, diphenhydramine hydrochloride, famotidine, dioxpromazine hydrochloride and levofloxacin mesylate. The annual output of preparations is more than 2 billion tablets, mainly including chlorpipetin hydrochloride tablets and compound paracetamol diphenhydramine tablets. The company has import and export rights, and its products are mainly exported to India, Hong Kong, Macao, Taiwan and other countries and regions. The company has passed GMP certification and COS certification, and is applying for FDA certification to obtain a pass for products to enter the European and American markets.

Staff size:About 400 persons

Registered capital:RMB 50 million